Lv4
624 积分 2022-11-12 加入
Interferon-induced senescent CD8 + T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
24天前
已完结
Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma
25天前
已关闭
Upper Urinary Tract Urothelial Cell Carcinomas and Other Urological Malignancies Involved in the Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) Tumor Spectrum
27天前
已完结
Practical guidance for mismatch repair-deficiency testing in endometrial cancer
27天前
已完结
Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis
28天前
已完结
Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma
29天前
已关闭
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
1个月前
已完结
Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma
1个月前
已完结
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
1个月前
已完结
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study
1个月前
已完结
皖公网安备34019202002308
